Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 Jul 24 EFFECT Notice of effectiveness
- 12 Jul 24 424B3 Prospectus supplement
- 11 Jul 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 11 Jul 24 S-4/A Registration of securities issued in business combination transactions (amended)
-
17 Jun 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 3 May 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 30 Jan 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 13 Nov 23 S-4 Registration of securities issued in business combination transactions
CTOR similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Amendment No. 3 to the Registration Statement (No. 333-275506) on Form S-4 of TenX Keane Acquisition of our report dated January 4, 2024, relating to the financial statements of Citius Oncology, Inc., appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the caption “Experts” in such Prospectus.
/s/ Wolf & Company, P.C.
Boston, Massachusetts
June 17, 2024